Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial.
Författare
Summary, in English
In rheumatoid arthritis (RA), predictive biomarkers for subsequent radiographic progression (RP) could improve therapeutic choices for individual patients. We previously showed that the multibiomarker disease activity (MBDA) score in patients with newly diagnosed RA identified patients at risk for RP. We evaluated the MBDA score at multiple time-points as a predictor of RP during 2 years of follow-up.
Avdelning/ar
Publiceringsår
2016
Språk
Engelska
Sidor
000197-000197
Publikation/Tidskrift/Serie
RMD Open
Volym
2
Issue
1
Länkar
Dokumenttyp
Artikel i tidskrift
Förlag
BMJ Publishing Group
Ämne
- Rheumatology and Autoimmunity
Status
Published
Forskningsgrupp
- Lund Arthritis Research Group (LARG)
ISBN/ISSN/Övrigt
- ISSN: 2056-5933